PRIMOBOLAN 100 (Methenolone Enanthate) is a long-acting anabolic steroid commonly prescribed for the management of conditions characterized by muscle wasting, such as aplastic anemia, postmenopausal osteoporosis, breast cancer, sarcopenia, and cachexia. It is also used as an adjunct therapy in patients with compromised immune systems due to chronic illness or infections. Each milliliter of this injectable formulation contains 100mg of methenolone enanthate, delivered in a sterile oil solution with suitable excipients for intramuscular administration.
Metabolic Interactions
Methenolone enanthate is a depot ester of methenolone, which upon administration is hydrolyzed to its active form. It binds to androgen receptors, eliciting mild androgenic and moderate anabolic effects. Unlike other anabolic agents, methenolone has minimal to no estrogenic activity, making it particularly suitable for individuals susceptible to estrogen-mediated side effects. Its anabolic influence on bone marrow function further supports its use in anemic conditions, enhancing erythropoiesis without compromising hormonal balance.
Dosage
A typical therapeutic dose involves intramuscular administration of 100mg, with frequency tailored to individual clinical needs and treatment goals.
Drug Interactions
Clinicians should exercise caution and evaluate potential pharmacological interactions when methenolone enanthate is administered concurrently with:
Betamethasone phosphate
Ciclesonide
Budesonide
Side Effects
Adverse effects reported with PRIMOBOLAN 100 include:
Symptoms of virilization in women (e.g., voice deepening, hirsutism)
Acneiform eruptions
Elevated libido
Reversible suppression of endogenous testosterone production (hypogonadism)